What a real handover contains
A handover between your home medical team and a China surgical team is not a courtesy email. It is the transfer of enough clinical information for each side to make safe decisions and to know what the other side is doing. For robotic prostatectomy, that means the China team needs your existing diagnosis, biopsy pathology, imaging, prostate-specific antigen history, medicines and relevant past surgery. Your home team needs the China team's assessment of cancer stage and risk, the planned operation and its scope, the pathology findings after surgery, and the follow-up plan.
The exchange has to work in both directions. If only the China team receives records, your home clinicians cannot plan follow-up or interpret a later PSA result. If only your home team receives a discharge summary, the China team cannot adjust anything based on your prior treatment. Ask both sides what they will send, to whom, and when. A named recipient is more useful than a general department address.
Keep the exchange factual. A handover is not a second opinion request unless you ask for one. If you want your home urologist to comment on the China plan, say so explicitly and give them the same documents the China team used.
Cancer-control and functional priorities: what the teams need to know
Robotic prostatectomy removes the prostate for selected prostate cancers, and the surgeon controls robotic instruments rather than operating directly by hand. The operation sits at the intersection of two goals: treating the cancer and preserving urinary and sexual function where that is realistic. Those goals can pull in different directions, and the balance is not the same for every patient.
Your home team often holds the history that shapes this balance. They may know your baseline urinary function, your erectile function before diagnosis, your other conditions, and how you have responded to previous treatment. The China team needs that baseline to interpret what changes after surgery. Ask your home clinicians to write a short functional baseline: what was normal for you, what was already reduced, and what you were told about nerve-sparing or other technical options.
Then ask the China team how it weighs cancer control against functional preservation in your case, and what uncertainty remains. You are not asking for a guarantee. You are asking what the plan assumes, what could change it, and what alternatives exist. If the two teams disagree, that disagreement is useful information, not a problem to hide. Ask each side what evidence would change its recommendation.
Pathology review and staging: closing the loop
Staging and pathology are the backbone of a prostatectomy decision and of follow-up. Before surgery, the China team will review your biopsy and imaging. After surgery, the removed prostate is examined and a pathology report describes what was found. Your home team needs that post-operative report to plan surveillance and to interpret future tests.
Ask how the pathology will be reviewed and who will send the final report to your home clinicians. If your home team wants to re-review the slides or images, ask what format and what timeframe they need. Do not assume that a report will be automatically forwarded; confirm the route. If a preliminary reply arrives before the final report, treat it as preliminary and ask what remains outstanding.
A pathology review is not a formality. It can change staging, margin status and the follow-up plan. If the China and home readings differ, ask both pathologists to explain the basis for their interpretation rather than choosing one silently.
Catheter care and early recovery questions to confirm
Catheter management after prostatectomy is a practical area where instructions must come from the treating team, not from a general guide. Ask the China team what catheter care is expected, who will remove it, what warning signs require urgent contact, and what written instructions you will receive before discharge. Ask the same questions of your home team if follow-up will happen after you return.
Do not assume that catheter timelines, activity restrictions or wound care are identical between the two settings. Ask each team to state its own instructions in writing, and ask what to do if the two sets of instructions conflict. The treating clinician responsible for your care at that moment should make the decision.
Recovery support also includes practical questions: who will manage pain relief, who will review any urinary symptoms, and how you will contact the surgical team after you leave China. Confirm the contact route and the expected response process rather than relying on a general phone number.
Continuing follow-up: who does what after you return home
Follow-up is where cross-border surgical care can come apart. Before you travel, agree in writing who will check your PSA, when, and who will act on the result. Ask the China team what follow-up it recommends and ask your home team whether it can provide that follow-up. If the answer is no, ask what alternative arrangement is possible before you commit to surgery abroad.
Follow-up is not only blood tests. It includes functional recovery, continence and sexual function, and any additional treatment if pathology shows a need. Ask each team which parts it will handle and where the records will live. If your home team will take over, make sure it has the operative note, discharge summary and pathology report, not just a verbal account.
If your home team wants to discuss the case with the China team, ask whether a direct clinician-to-clinician conversation can be arranged. That conversation is often more useful than another round of documents, but it needs a named contact and a confirmed time.
Practical steps before you travel
Build the handover before the operation, not after. Collect your biopsy report, imaging, PSA history, medicine list and functional baseline. Ask your home team to write a short summary of prior treatment and what it wants from the China team. Ask the China team what records it needs and in what format.
Confirm the exchange route in writing: who sends what, to whom, and by when. Ask both sides what they will do with the information and who is responsible for the next step. If you want help with records, interpretation or requesting a specialist appointment in China, ChinaSpecialistCare can coordinate that as a non-clinical service; the hospital and licensed clinicians decide suitability and treatment.
Start with a free initial enquiry and a brief summary of your situation. You do not need to buy a proxy consultation to ask a question. The hospital decides whether robotic prostatectomy is appropriate for you, and your home team remains part of the plan.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.